Each year around 30,000 people in the UK are diagnosed with a form of blood cancer; 12,000 people die annually from the disease. Southampton researchers are bringing hope by gaining a better understanding of the illnesses and paving the way for potential new treatments.
The quality of our research has been recognised by the charity Leukemia & Lymphoma Research. We are one of the charity’s Centres of Excellence and it is investing over £7m into studies at Southampton. The funds support a number of projects which are making significant breakthroughs in the understanding, diagnosis and treatment of blood cancers.
Chronic lymphocytic leukaemia (CLL) is the focus of two research projects. One aims to understand how the cancer cells proliferate, in order to enable the development of new drugs in the future. A second project is identifying genes that can predict how well patients with CLL will respond to treatment, to help doctors identify suitable treatment pathways for patients and enable the design of more targeted treatments.
Cathy Gilman, Chief Executive of Leukaemia & Lymphoma Research, says: “The University of Southampton has proved itself to be truly world class in its research into blood cancers. Scientists here are consistently helping to improve treatment and diagnosis for patients in Southampton and across the UK.”
Other University of Southampton sites
Links to external websites
The University cannot accept responsibility for external websites.